We’re hoping to see more early-stage funding in 2026 to help newer companies get off the ground. The public market, ...

For the first time, the tools to rewrite human biology are moving from speculative fiction into regulated clinics and ...

FAYETTEVILLE, GA, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- Understanding why cancer cells rely on specific ...

From diagnostics to CRISPR and policy reform, explore how science and society are working together to combat the rising ...

Illumina’s Billion Cell Atlas aims to standardize massive CRISPR perturbation data to make biological response patterns more ...

The AHA recommended whole exome or whole genome sequencing as first-line diagnostic tools for mitochondrial diseases.

For over a century, scientists have been fascinated by bacteriophages, the tiny viruses that naturally hunt and kill bacteria. University of Otago researchers are turning to these microscopic ...

科学家发现160年来首个新型植物组织，大幅提高作物产量 ...

We came across a bullish thesis on Recursion Pharmaceuticals, Inc. on r/stocks by Antique-Reference585. In this article, we ...

Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, releases the following letter to stockholders from ...

Cathie Wood's Ark Invest unveiled its "big ideas" for 2025 in a cryptic list, challenging users to interpret a series of ...

Overview: Emerging technologies in 2026 are pushing the boundaries of what’s possible across industries, from healthcare to ...